[Retracted] Novel lncRNA AL033381.2 Promotes Hepatocellular Carcinoma Progression by Upregulating PRKRA Expression

Table 1

Analysis of the significant difference of AL033381.2 expression level in clinicopathologic characteristics.

Clinical parameters	AL033381.2 expression		Total	value
	Low expression	High expression
Pathological grade
G1/2	149	83	232	0.119
G3/4	75	59	134
Total	224	142	366
T stage
T1	121	60	181	0.032
T2	53	41	94
T3/4	51	42	93
Total	225	143	368
TNM
Stage I	115	56	171	0.011
Stage II	51	35	86
Stage III/IV	46	44	90
Total	212	135	347

Statistical analyses were performed by the Mann-Whitney test. value < 0.05 was considered statistically significant.